Medicine
Exforge 10 mg/160 mg tablet
Exforge 10 mg/160 mg tablet is a prescription medicine containing Amlodipine and Valsartan for oral use, marketed by Novartis Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C-25°C (68°F-77°F), excursions permitted between 15°C and 30°C…
Key facts
- Active ingredient (INN)
- Amlodipine and Valsartan
- Brand
- Exforge
- Strength
- 10 mg/160 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Novartis Pharmaceuticals
- Manufacturer
- Novartis Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C-25°C (68°F-77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09DB01 Amlodipine and Valsartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 June 2007
- Identifiers
- RxCUI 722126, 722131, 722134 +5DailyMed set ID d0caec89-96ec-411d-a933-63eda74a6da7NDC 0078-0489Application NDA021990
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0078-0489-15 | Novartis Pharmaceuticals | 20 June 2007 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Amlodipine and Valsartan 10 mg/160 mg tablet.
Other strengths and forms of Amlodipine and Valsartan
Clinical summary
Amlodipine and Valsartan is a fixed-dose combination of an angiotensin 2 receptor blocker, a calcium channel blocker and a dihydropyridine calcium channel blocker indicated for the treatment of hypertension, to lower blood pressure. MedsAcross supplies Amlodipine and Valsartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Amlodipine and ValsartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Exforge prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Copalia: European public assessment report (EPAR) · European Medicines Agency
- Dafiro: European public assessment report (EPAR) · European Medicines Agency
Need Exforge 10 mg/160 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.